|
1
|
Clarke-Pearson DL: Clinical practice.
Screening for ovarian cancer. N Engl J Med. 361:170–177. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Diaz-Gil D, Fintelmann FJ, Molaei S, Elmi
A, Hedgire SS and Harisinghani MG: Prediction of 5-year survival in
advanced-stage ovarian cancer patients based on computed tomography
peritoneal carcinomatosis index. Abdom Radiol (NY). 41:2196–2202.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pignata S, Cannella L, Leopardo D, Pisano
C, Bruni GS and Facchini G: Chemotherapy in epithelial ovarian
cancer. Cancer Lett. 303:73–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kurman RJ and Shih IeM: The origin and
pathogenesis of epithelial ovarian cancer: A proposed unifying
theory. Am J Surg Pathol. 34:433–443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vaughan S, Coward JI, Bast RC Jr, Berchuck
A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R,
Etemadmoghadam D, et al: Rethinking ovarian cancer: Recommendations
for improving outcomes. Nat Rev Cancer. 11:719–725. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huarte M and Rinn JL: Large non-coding
RNAs: Missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Li Z, Liu L, Wang Q, Li S, Chen
D, Hu Z, Yu T, Ding J, Li J, et al: Long noncoding RNA TSLNC8 is a
tumor suppressor that inactivates the interleukin-6/STAT3 signaling
pathway. Hepatology. 67:171–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shih JW, Chiang WF, Wu ATH, Wu MH, Wang
LY, Yu YL, Hung YW, Wang WC, Chu CY, Hung CL, et al: Long noncoding
RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer
progression. Nat Commun. 8:158742017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen ZZ, Huang L, Wu YH, Zhai WJ, Zhu PP
and Gao YF: LncSox4 promotes the self-renewal of liver
tumour-initiating cells through Stat3-mediated Sox4 expression. Nat
Commun. 7:125982016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martini P, Paracchini L, Caratti G,
Mello-Grand M, Fruscio R, Beltrame L, Calura E, Sales G, Ravaggi A,
Bignotti E, et al: lncRNAs as novel indicators of patients'
prognosis in stage I epithelial ovarian cancer: A retrospective and
multicentric study. Clin Cancer Res. 23:2356–2366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fujiwara K, McAlpine JN, Lheureux S,
Matsumura N and Oza AM: Paradigm shift in the management strategy
for epithelial ovarian cancer. Am Soc Clin Oncol Educ Book.
35:e247–e257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Montagnana M, Benati M and Danese E:
Circulating biomarkers in epithelial ovarian cancer diagnosis: From
present to future perspective. Ann Transl Med. 5:2762017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Semin Surg
Oncol. 19:3–10e. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun X, Zhang W, Li H, Niu C, Ou Y, Song L
and Zhang Y: Stonin 2 overexpression is correlated with unfavorable
prognosis and tumor invasion in epithelial ovarian cancer. Int J
Mol Sci. 18:pii: E1653. 2017. View Article : Google Scholar
|
|
21
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology.
58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bagnoli M, Canevari S, Califano D, Losito
S, Maio MD, Raspagliesi F, Carcangiu ML, Toffoli G, Cecchin E,
Sorio R, et al: Development and validation of a microRNA-based
signature (MiROvaR) to predict early relapse or progression of
epithelial ovarian cancer: A cohort study. Lancet Oncol.
17:1137–1146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Walsh CS, Ogawa S, Karahashi H, Scoles DR,
Pavelka JC, Tran H, Miller CW, Kawamata N, Ginther C, Dering J, et
al: ERCC5 is a novel biomarker of ovarian cancer prognosis. J Clin
Oncol. 26:2952–2958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gagnon A and Ye B: Discovery and
application of protein biomarkers for ovarian cancer. Curr Opin
Obstet Gynecol. 20:9–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xing Z, Lin A, Li C, Liang K, Wang S, Liu
Y, Park PK, Qin L, Wei Y, Hawke DH, et al: lncRNA directs
cooperative epigenetic regulation downstream of chemokine signals.
Cell. 159:1110–1125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Trimarchi T, Bilal E, Ntziachristos P,
Fabbri G, Dalla-Favera R, Tsirigos A and Aifantis I: Genome-wide
mapping and characterization of Notch-regulated long noncoding RNAs
in acute leukemia. Cell. 158:593–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abraham JM and Meltzer SJ: Long noncoding
RNAs in the pathogenesis of barrett's esophagus and esophageal
carcinoma. Gastroenterology. 153:27–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hua F, Li CH, Chen XG and Liu XP: Long
noncoding RNA CCAT2 knockdown suppresses tumorous progression by
sponging miR-424 in epithelial ovarian cancer. Oncol Res.
26:241–247. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiu YL, Sun KX, Chen X, Chen S, Zhao Y,
Guo QG and Zong ZH: Upregulation of the lncRNA Meg3 induces
autophagy to inhibit tumorigenesis and progression of epithelial
ovarian carcinoma by regulating activity of ATG3. Oncotarget.
8:31714–31725. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Scaletta G, Plotti F, Luvero D,
Capriglione S, Montera R, Miranda A, Lopez S, Terranova C, De Cicco
Nardone C and Angioli R: The role of novel biomarker HE4 in the
diagnosis, prognosis and follow-up of ovarian cancer: A systematic
review. Expert Rev Anticancer Ther. 17:827–839. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Resnick KE, Alder H, Hagan JP, Richardson
DL, Croce CM and Cohn DE: The detection of differentially expressed
microRNAs from the serum of ovarian cancer patients using a novel
real-time PCR platform. Gynecol Oncol. 112:55–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kan CW, Hahn MA, Gard GB, Maidens J, Huh
JY, Marsh DJ and Howell VM: Elevated levels of circulating
microRNA-200 family members correlate with serous epithelial
ovarian cancer. BMC Cancer. 12:6272012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo F, Tian J, Lin Y, Jin Y, Wang L and
Cui M: Serum microRNA-92 expression in patients with ovarian
epithelial carcinoma. J Int Med Res. 41:1456–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang F, Yuan JH, Wang SB, Yang F, Yuan SX,
Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH: Oncofetal long
noncoding RNA PVT1 promotes proliferation and stem cell-like
property of hepatocellular carcinoma cells by stabilizing NOP2.
Hepatology. 60:1278–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
